Health Catalyst, Inc.
HCATNasdaqCIK 1636422TechnologyFiscal year ends Dec 31
Reports and events: 122 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1420:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001636422-26-000111 |
| 2026-09-0821:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-105948 |
| 2026-09-0812:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001636422-26-000104 |
| 2026-08-0620:58 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001636422-26-000097 |
| 2026-08-0620:09 ET | 8-K | 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001636422-26-000091 |
| 2026-07-2022:40 ET | 8-K | 5.07 Shareholder vote results | 0001636422-26-000085 |
| 2026-06-2219:55 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-26-076342 |
| 2026-06-0823:12 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001607278-26-000004 |
| 2026-06-0413:10 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001636422-26-000082 |
| 2026-06-0320:11 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001636422-26-000075 |
| 2026-05-1121:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001636422-26-000066 |
| 2026-05-1120:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636422-26-000064 |
| 2026-04-3021:19 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001636422-26-000055 |
| 2026-04-3013:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001636422-26-000051 |
| 2026-04-2713:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001636422-26-000045 |
| 2026-04-0321:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001636422-26-000042 |
| 2026-03-1300:09 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000929638-26-001019 |
| 2026-03-1220:58 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001636422-26-000035 |
| 2026-03-1220:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636422-26-000031 |
| 2026-02-1818:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-056586 |
| 2026-02-1813:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001636422-26-000015 |
| 2026-01-2321:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001636422-26-000010 |
| 2026-01-2113:39 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-017290 |
| 2026-01-1221:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636422-26-000006 |
| 2025-12-0321:03 ET | SCHEDULE 13D | Ownership report, active investor | 0000929638-25-004499 |
| 2025-12-0212:10 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001636422-25-000156 |
| 2025-11-1021:36 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001636422-25-000146 |
| 2025-11-1021:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636422-25-000143 |
| 2025-09-1021:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001636422-25-000133 |
| 2025-08-0820:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001636422-25-000111 |
| 2025-08-0720:11 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001636422-25-000108 |
| 2025-07-1021:26 ET | 8-K | 5.07 Shareholder vote results | 0001636422-25-000096 |
| 2025-05-1920:22 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001636422-25-000075 |
| 2025-05-0920:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001636422-25-000069 |
| 2025-05-0720:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636422-25-000063 |
| 2025-04-3020:32 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001636422-25-000051 |
| 2025-02-2622:07 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001636422-25-000028 |
| 2025-02-2621:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001636422-25-000023 |
| 2025-01-1313:54 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events | 0001636422-25-000010 |
| 2024-11-0723:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001636422-24-000152 |
| 2024-11-0621:09 ET | 8-K | 2.02 Results of operations; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001636422-24-000148 |
| 2024-08-0822:50 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001636422-24-000120 |
| 2024-08-0720:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636422-24-000116 |
| 2024-07-1813:09 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001636422-24-000107 |
| 2024-06-1720:36 ET | 8-K | 5.07 Shareholder vote results | 0001636422-24-000097 |
| 2024-05-1022:25 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001636422-24-000075 |
| 2024-05-0920:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001636422-24-000072 |
| 2024-04-2921:08 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001636422-24-000058 |
| 2024-04-2320:42 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001636422-24-000050 |
| 2024-02-2222:28 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001636422-24-000016 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.